ABSTRACT:
The protection and directed digestion of dynamic mixtures are vital because of their vulnerability to debasement. This matter can be really tended to by the use of strong lipid nanoparticles (SLNs) for embodiment. The usage of beginning strong lipid nanoparticles (SLNs) was pervasive in the exemplification of non-polar, hydrophobic dynamic mixtures attributable to their solid fascination and associations. Strong lipid nanoparticles (SLNs) are regularly used to exemplify hydrophilic and semipolar dynamic mixtures. Be that as it may, there are still difficulties to survive, for example, upgrading the adequacy of capture. This review gives an outline of the most recent examination on strong lipid nanoparticles (SLNs) for the exemplification and conveyance of dynamic and cell reinforcement compounds. It incorporates inclusion of creation techniques and applications across numerous areas. Strong lipid nanoparticles (SLNs) can be incorporated by the cautious choice of strong lipid networks, emulsifiers/surfactants, dynamic mixtures/cell reinforcements, amalgamation methods, and expected applications. The choice of lipid affects the course of gem arrangement, the arrival of dynamic fixings, and the viability of embodiment. SLN assembling of dynamic mixtures and hydrophilic/hydrophobic cell reinforcements includes different strategies, each having benefits and drawbacks. The qualities of SLN are dependent upon the plan of assembling, which involves the choice of lipid networks, surfactants, and strategies. The high-shear homogenization technique with ultrasonication is usually utilized on the grounds that to its advantageous planning process and ideal outcomes. Strong lipid nanoparticles (SLNs) containing stable dynamic mixtures and cell reinforcements can be integrated through proper assembling configuration, delivering them reasonable for a large number of uses.
Cite this article:
Vedanshu Malviya, Srikant Pande. A Review of the Most Recent Research on Solid Lipid Nanoparticles, Focusing on Active Compound Encapsulation. Research Journal of Pharmacy and Technology. 2025;18(4):1658-2. doi: 10.52711/0974-360X.2025.00237
Cite(Electronic):
Vedanshu Malviya, Srikant Pande. A Review of the Most Recent Research on Solid Lipid Nanoparticles, Focusing on Active Compound Encapsulation. Research Journal of Pharmacy and Technology. 2025;18(4):1658-2. doi: 10.52711/0974-360X.2025.00237 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-4-28
REFERENCES:
1. Garces A, Amaral MH, Lobo JS, Silva AC. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. European Journal of Pharmaceutical Sciences. 2018; Jan 15; 112: 159-67. DOI: 10.1016/j.ejps.2017.11.023
2. Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. International Current Pharmaceutical Journal. 2012; Oct 3; 1(11): 384-93. DOI:10.3329/icpj.v1i11.12065
3. Ram DT, Debnath S, Babu MN, Nath TC, Thejeswi B. A review on solid lipid nanoparticles. Research Journal of Pharmacy and Technology. 2012; Nov 1; 5(11): 2. DOI: 10.5958/0974-360X
4. Sachin J, Gupta NV. Solid lipid nanoparticles–preparation, applications, characterization, uses in various cancer therapies: a review. Research Journal of Pharmacy and Technology. 2013; 6(8): 825-37. DOI: 10.5958/0974-360X
5. Sanghavi S, Polara M, Patel D, Shah R, Patel J, Patel M. Nanoparticle drug delivery to brain–A Review. Research Journal of Pharmacy and Technology. 2012; 5(1): 8-13. DOI: 10.5958/0974-360X
6. Anagha B, Shivanand H, Manoj A, Poonam P. Effect of lipids and surfactants on solid lipid nanoparticle engineering. Research Journal of Pharmacy and Technology. 2011; 4(4): 521-6. DOI: 10.5958/0974-360X
7. Mulla JA, Suresh S, Khazi IA. Formulation, characterization and in vitro evaluation of methotrexate solid lipid nanoparticles. Research Journal of Pharmacy and Technology. 2009; 2(4): 685-9. DOI: 10.5958/0974-360X
8. Chaudhari NB, Zalte AG, Gulecha VS. Formulation, optimization, characterization and in vitro-ex vivo evaluation of atorvastatin loaded solid lipid nanoparticles using quality by design approach. Research Journal of Pharmacy and Technology. 2023; Mar 1; 16(3): 1433-41. DOI: 10.52711/0974-360X.2023.00236
9. Sharma S, Ashawat MS, Solanki NS. Isotretinoin-Loaded Solid-Lipid Nanoparticles: A Sound Strategy for Skin Targeting. Research Journal of Pharmacy and Technology. 2012; 5(11): 1375-84. DOI: 10.5958/0974-360X
10. Reddy SH, Umashankar MS, Damodharan N. Formulation, Characterization and Applications on Solid Lipid Nanoparticles-A Review. Research Journal of Pharmacy and Technology. 2018; 11(12): 5691-700. DOI: 10.5958/0974-360X.2018.01031.4
11. Sujan MN, Patil AB, Gowda DV. A Review on Methods of Preparation and Characterisation of the solid Lipid Nanoparticles. Research Journal of Pharmacy and Technology. 2020; 13(7): 3433-41. DOI: 10.5958/0974-360X.2020.00610.1
12. Jangde RK, Khan T, Bhardwaj H. Development and Characterization of Nanostructured Lipid Carrier for Topical delivery of Naringenin. Research Journal of Pharmacy and Technology. 2023; May 1; 16(5): 2572-6. DOI: 10.52711/0974-360X.2023.00422
13. Üner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die Pharmazie-an international Journal of Pharmaceutical Sciences. 2006; May 1; 61(5): 375-86.
14. Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. International Journal of Nanomedicine. 2007; Dec 1; 2(3): 289-300.
15. H Muller R, Shegokar R, M Keck C. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Current drug Discovery Technologies. 2011; Sep 1; 8(3): 207-27. DOI: 10.2174/157016311796799062
16. Alsaad AA, Hussien AA, Gareeb MM. Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review. Syst. Rev. Pharm. 2020; May 1; 11: 259-73. DOI: 10.31838/srp.2020.5.39
17. Saez V, Souza ID, Mansur CR. Lipid nanoparticles (SLN and NLC) for delivery of vitamin E: A comprehensive review. International Journal of Cosmetic Science. 2018; Apr; 40(2): 103-16. https://doi.org/10.1111/ics.12452
18. Burg LC, Verheijen S, Bekkers RL, IntHout J, Holloway RW, Taskin S, Ferguson SE, Xue Y, Ditto A, Baiocchi G, Papadia A. The added value of SLN mapping with indocyanine green in low-and intermediate-risk endometrial cancer management: A systematic review and meta-analysis. Journal of Gynecologic Oncology. 2022 Sep;33(5). doi: 10.3802/jgo.2022.33.e66
19. Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MH, Silva AM, Souto EB. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. Journal of Drug Delivery. 2012;2012. DOI: 10.1155/2012/750891
20. Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. Journal of Biomedical Nanotechnology. 2007 Dec 1; 3(4): 317-31. DOI:10.1166/jbn.2007.049
21. Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers. Int J Pharm Pharm Sci. 2010; 2(4): 30-5.
22. Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part I–Barriers and determining factors in ocular delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2017; Jan 1; 110: 70-5. DOI: 10.1016/j.ejpb.2016.10.009
23. Parashar AK, Kakde D, Chadhar V, Devaliya R, Shrivastav V, Jain UK. A review on solid lipid nanoparticles (SLN) for controlled and targeted delivery of medicinal agents. Current Research in Pharmaceutical Sciences. 2011; Dec 31: 37-47.
24. Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC. In vitro studies on nasal formulations of nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN). Pharmaceuticals. 2021; Jul 23; 14(8): 711. DOI: 10.3390/ph14080711
25. Souto EB, Müller RH. Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®). International journal of cosmetic science. 2008; 30(3): 157-65. DOI: 10.1111/j.1468-2494.2008.00433.x
26. Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, Severino P, Paganelli MO, Chaud MV, Silva AM. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022; 8(2): e08938. DOI: 10.1016/j.heliyon.2022.e08938
27. Campos JR, Severino P, Santini A, Silva AM, Shegokar R, Souto SB, Souto EB. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties. Nanopharmaceuticals. 2020; 1-5. DOI:10.1016/B978-0-12-817778-5.00001-4
28. Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as innovative drug delivery systems for non-invasive routes of drug administration. Current Medicinal Chemistry. 2020; 27(22): 3623-56. DOI: 10.2174/0929867326666190624155938
29. Meads C, Sutton AJ, Rosenthal AN, Małysiak S, Kowalska M, Zapalska A, Rogozińska E, Baldwin P, Ganesan R, Borowiack E, Barton P. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. British Journal of Cancer. 2014; Jun; 110(12): 2837-46. DOI: 10.1038/bjc.2014.205
30. Pardeshi C, Rajput P, Belgamwar V, Tekade A, Patil G, Chaudhary K, Sonje A. Solid lipid based nanocarriers: An overview/Nanonosaci na bazi čvrstih lipida: Pregled. Acta Pharmaceutica. 2012; Dec 1; 62(4): 433-72. DOI: 10.2478/v10007-012-0040-z
31. Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Advanced Drug Delivery Reviews. 2007; Jul 10; 59(6): 411-8. DOI: 10.1016/j.addr.2007.04.004
32. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced Drug Delivery Reviews. 2007; 59(6): 478-90. DOI: 10.1016/j.addr.2007.04.007
33. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews. 2012; 64: 83-101. DOI: 10.1016/s0169-409x(01)00105-3
34. Yadav N, Khatak S, Sara US. Solid lipid nanoparticles-a review. Int. J. Appl. Pharm. 2013; 5(2): 8-18.
35. Ganesan P, Ramalingam P, Karthivashan G, Ko YT, Choi DK. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. International Journal of Nanomedicine. 2018; Mar 15: 1569-83. DOI: 10.2147/IJN.S155593